Compare PSN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSN | HAE |
|---|---|---|
| Founded | 1944 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2019 | 1996 |
| Metric | PSN | HAE |
|---|---|---|
| Price | $50.48 | $119.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $59.91 | ★ $124.50 |
| AVG Volume (30 Days) | ★ 1.1M | 669.3K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.77 | N/A |
| EPS | ★ 0.85 | 0.72 |
| Revenue | ★ $6,364,245,000.00 | $910,373,000.00 |
| Revenue This Year | N/A | $6.21 |
| Revenue Next Year | $5.15 | $5.54 |
| P/E Ratio | ★ $58.09 | $166.49 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $36.26 | $49.24 |
| 52 Week High | $88.00 | $123.77 |
| Indicator | PSN | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 68.49 | 62.21 |
| Support Level | $48.81 | $115.49 |
| Resistance Level | $52.95 | $123.77 |
| Average True Range (ATR) | 1.84 | 3.00 |
| MACD | 0.75 | -0.39 |
| Stochastic Oscillator | 87.85 | 46.12 |
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.